Fundz

Who to call at MucoLife Therapeutics, and when

Fundz watches for the moments MucoLife Therapeutics starts buying, and tells you who to reach.

  • An alert the day MucoLife Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MucoLife Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MucoLife Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

MucoLife Therapeutics secures €91K from Vinnova to scale manufacturing of COPD treatment. The funding will support the establishment of a scalable manufacturing process for MLT-001.

Nov 07, 2026

Description

MucoLife Therapeutics has received €91,000 (SEK 1 million) from Vinnova, Sweden’s innovation agency, to develop a scalable manufacturing process for MLT-001, a therapy for chronic obstructive pulmonary disease (COPD). This grant will help in the purification process and advance the treatment closer to clinical trials. The company aims to achieve a suitable level of purity at a documented yield, in collaboration with a CDMO partner. This funding is crucial for turning MLT-001 into a viable medicine.

Company Information

Company

MucoLife Therapeutics

About

MucoLife Therapeutics is focused on developing innovative treatments for chronic obstructive pulmonary disease (COPD), specifically targeting mucus obstruction. Their first-in-class drug, MLT-001, is designed to dissolve airway mucus plugs in patients with moderate-to-severe COPD. The company aims to enhance the synthesis and manufacturing process to bring their treatment closer to clinical trials.

Predictive Intelligence
Strategic

ML-powered predictions for MucoLife Therapeutics's next move

Learn about Strategic plan

MucoLife Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.